Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine
Clinical trial NCT04456634 · COMPLETED
Trial details
- NCT number
- NCT04456634
- Sponsor
- Medicines for Malaria Venture
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2020-11-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.